Loading clinical trials...
Loading clinical trials...
Evaluate the efficacy, safety and tolerability of a single intraoperative dose of 4975 in patients undergoing total hip replacement
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Anesiva, Inc.
NCT07360392 · Arthroplasty, Replacement, Knee, Pain, Postoperative, and more
NCT06917365 · Total Hip Arthroplasty (THA)
NCT07410000 · Pain Management, Total Hip Arthroplasty
NCT04454203 · Tourniquet Hypertension, Intraoperative Hypertension, and more
NCT07225751 · Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion, and more
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama
Lotus Clinical Research, Inc.
Arcadia, California
Glendale Adventist Medical Center
Glendale, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions